Rabi Tawil
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
339
Citations
20,667
Est. group size
~2
Recurring co-author estimate
Active years
36
Publishing since 1991
Rabi Tawil's research focuses on facioscapulohumeral muscular dystrophy (FSHD) and related neuromuscular diseases, combining clinical trials, imaging, and molecular biology approaches to understand disease progression and identify biomarkers. Work includes testing new drugs (like losmapimod), developing muscle imaging techniques (electrical impedance myography, MRI, 3D modeling), and studying the genetic and epigenetic mechanisms (such as SMCHD1 and DUX4 gene activation) underlying muscle degeneration.
Publication output was higher around 2017 but has declined and stabilized at a lower, steady level of roughly 9-10 papers per year over the past several years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH study
Journal of Neuromuscular Diseases · 2026
- Late-onset facioscapulohumeral muscular dystrophy defines a distinct clinical subgroup
Neuromuscular Disorders · 2026
- Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy
Annals of Neurology · 2026
- SMCHD1 maintains heterochromatin, genome compartments and epigenome landscape in human myoblasts
Nature Communications · 2025
- 3D finite element models reveal regional fatty infiltration modulates tibialis anterior force generating capacity in FSHD
PLoS ONE · 2025
- Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients.
Scientific Reports · 2025
- Strength and functional correlates of reachable workspace in facioscapulohumeral muscular dystrophy
Neuromuscular Disorders · 2025
- Concurrent Inclusion Body Myositis and Late Onset Pompe Disease: A Case Report
Muscle & Nerve · 2025
- SLC34A2 as a Protein Biomarker for Facioscapulohumeral Muscular Dystrophy (FSHD) <i>in-vitro</i> and <i>in-situ</i>
Physiology · 2025
- 3D finite element models reveal regional fatty infiltration modulates tibialis anterior force generating capacity in FSHD
medRxiv · 2025
- Electrical Impedance Myography Captures Features of Macroscopic and Microscopic Muscle Structure in Facioscapulohumeral Muscular Dystrophy (P5-11.029)
Neurology · 2025
- Electrical impedance myography captures features of muscle structure measured by MRI and transcriptomic analysis in facioscapulohumeral muscular dystrophy
Journal of Neuromuscular Diseases · 2025
- A pilot study using actigraphy to examine activity performance and its relationship with activity capacity in adults with facioscapulohumeral muscular dystrophy
Journal of Neuromuscular Diseases · 2025
- A longitudinal study of disease progression in facioscapulohumeral muscular dystrophy (<scp>FSHD</scp>)
Muscle & Nerve · 2024
- Three-dimensional tissue engineered skeletal muscle modelling facioscapulohumeral muscular dystrophy
Brain · 2024
- Figshare×38
- Neuromuscular Disorders×25
- Neurology×17
- Muscle & Nerve×14
- Human Molecular Genetics×11
- Anne M. Connolly
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Stefan Nicolau
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Wendy King
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Kevin M. Flanigan
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jerry R. Mendell
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile